Enhanced PKM2 activity also promotes glycolysis in LUAD cells and promotes tumor progression (Rogatzki et al., 2015; Yin et al., 2020; Wang L. et al., 2024; Deng et al., 2022). The gene discussed is PKM; the disease is neoplasm.